SCHEMBL19984884

SCHEMBL19984884

CCCCc1ccc(Nc2cccc(OCC)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
HPGD P15428 3/20 0.48
GAA P10253 2/20 0.48
MAPT P10636 2/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
LMNA P02545 1/20 0.48
ALOX12 P18054 1/20 0.48
MAPK1 P28482 1/20 0.48
SYK P43405 1/20 0.45
TSHR P16473 1/20 0.45
MTNR1B P49286 3/20 0.44
MTNR1A P48039 2/20 0.44
NPC1 O15118 1/20 0.43
CASP3 P42574 1/20 0.43
RAB9A P51151 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
SENP8 Q96LD8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9274463 0.85 HPGD (0.50) ALDH1A1HPGDGAAMAPTMEN1
SCHEMBL11518974 0.83 SYK (0.57) ALDH1A1HPGDMAPTMEN1KMT2A
SCHEMBL9502179 0.82 SYK (0.47) MEN1KMT2ASMN1; SMN2SYKTSHR
SCHEMBL19979477 0.82 MTNR1B (0.55) ALDH1A1HPGDGAAMAPTMEN1
SCHEMBL24570956 0.82 MAPT (0.55) ALDH1A1HPGDGAAMAPTMEN1
SCHEMBL7986906 0.81 MAPT (0.54) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL11191264 0.80 MTNR1B (0.52) HPGDMAPTMEN1KMT2ALMNA
SCHEMBL1033939 0.79 NPSR1 (0.58) ALDH1A1HPGDGAAMAPTMEN1
SCHEMBL27587753 0.79 CYP3A4 (0.59) ALDH1A1GAAMAPTMEN1KMT2A
SCHEMBL1423027 0.79 UNG (0.54) ALDH1A1LMNAHSD17B10THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200407658-A1 ALKYLATED ALKOXYDIARYLAMINE ANTIOXIDANTS LANXESS SOLUTIONS US INC. (US) 2020-12-31 US disclosed
US-10808197-B2 Alkylated alkoxydiarylamine antioxidants LANXESS SOLUTIONS US INC. (US) 2020-10-20 US disclosed
WO-2018057365-A1 ALKYLATED ALKOXYDIARYLAMINE ANTIOXIDANTS LANXESS SOLUTIONS US INC. (US) 2018-03-29 WO disclosed
US-20180079984-A1 ALKYLATED ALKOXYDIARYLAMINE ANTIOXIDANTS LANXESS CORPORATION 2018-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10808197-B2 Alkylated alkoxydiarylamine antioxidants GPX4, CAT, SOD1 ALDH1A1 50/4885HPGD 601/4885GAA 2059/4885
US-20200407658-A1 ALKYLATED ALKOXYDIARYLAMINE ANTIOXIDANTS GPX4, CAT, SOD1 ALDH1A1 50/4885HPGD 601/4885GAA 2059/4885
US-20180079984-A1 ALKYLATED ALKOXYDIARYLAMINE ANTIOXIDANTS GPX4, CAT, SOD1 ALDH1A1 50/4885HPGD 601/4885GAA 2059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.